Acorah Software Products - Accounts Production 16.4.675 false true 31 March 2024 1 April 2023 false 1 April 2024 31 March 2025 31 March 2025 11278705 Mrs Susanne Schlegel Mr Anuj Gandhi iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 11278705 2024-03-31 11278705 2025-03-31 11278705 2024-04-01 2025-03-31 11278705 frs-core:CurrentFinancialInstruments 2025-03-31 11278705 frs-core:ComputerEquipment 2025-03-31 11278705 frs-core:ComputerEquipment 2024-04-01 2025-03-31 11278705 frs-core:ComputerEquipment 2024-03-31 11278705 frs-core:FurnitureFittings 2025-03-31 11278705 frs-core:FurnitureFittings 2024-04-01 2025-03-31 11278705 frs-core:FurnitureFittings 2024-03-31 11278705 frs-core:ShareCapital 2025-03-31 11278705 frs-core:RetainedEarningsAccumulatedLosses 2025-03-31 11278705 frs-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 11278705 frs-bus:FilletedAccounts 2024-04-01 2025-03-31 11278705 frs-bus:SmallEntities 2024-04-01 2025-03-31 11278705 frs-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 11278705 frs-bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 11278705 frs-bus:Director1 2024-04-01 2025-03-31 11278705 frs-bus:Director2 2024-04-01 2025-03-31 11278705 frs-countries:EnglandWales 2024-04-01 2025-03-31 11278705 2023-03-31 11278705 2024-03-31 11278705 2023-04-01 2024-03-31 11278705 frs-core:CurrentFinancialInstruments 2024-03-31 11278705 frs-core:ShareCapital 2024-03-31 11278705 frs-core:RetainedEarningsAccumulatedLosses 2024-03-31
Registered number: 11278705
Healthcaps Europe Ltd
Unaudited Financial Statements
For The Year Ended 31 March 2025
Healthcaps Europe Ltd
Contents
Contents

| Page
--- | ---
Balance Sheet | 1
Notes to the Financial Statements | 2—3

Page 1
Healthcaps Europe Ltd
Balance Sheet
As At 31 March 2025
Balance Sheet
Registered number: 11278705

| 2025 | 2024
--- | --- | ---
| Notes | £ | £ | £ | £
FIXED ASSETS
Tangible Assets | 4 |  | 643 |  | 550
|  |  | 643 |  | 550
CURRENT ASSETS
Stocks | 5 | 1,140,222 |  | 739,067 |
Debtors | 6 | 435,259 |  | 794,629 |
Cash at bank and in hand |  | 175,889 |  | 109,187 |
|  | 1,751,370 |  | 1,642,883 |
Creditors: Amounts Falling Due Within One Year | 7 | (2,112,427 ) |  | (1,748,025 ) |
NET CURRENT ASSETS (LIABILITIES) |  |  | (361,057 ) |  | (105,142 )
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | (360,414 ) |  | (104,592 )
NET LIABILITIES |  |  | (360,414 ) |  | (104,592 )
CAPITAL AND RESERVES
Called up share capital | 8 |  | 1 |  | 1
Profit and Loss Account |  |  | (360,415 ) |  | (104,593 )
SHAREHOLDERS' FUNDS |  |  | (360,414) |  | (104,592)

For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board

Mr Anuj Gandhi Director
13/11/2025

The notes on pages 2 to 3 form part of these financial statements.
Page 1
Page 2
Healthcaps Europe Ltd
Notes to the Financial Statements
For The Year Ended 31 March 2025
Notes to the Financial Statements
1. General Information
Healthcaps Europe Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 11278705 . The registered office is 2ND Floor College House, 17 King Edwards Road, Ruislip, London, HA4 7AE.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Fixtures & Fittings | 25% Staright Line Method
Computer Equipment | 25% Staright Line Method

2.4. Foreign Currencies
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2024: 2)
2 2
4. Tangible Assets

| Fixtures & Fittings | Computer Equipment | Total
--- | --- | --- | ---
| £ | £ | £
Cost
As at 1 April 2024 | - | 733 | 733
Additions | 368 | - | 368
As at 31 March 2025 | 368 | 733 | 1,101
Depreciation
As at 1 April 2024 | - | 183 | 183
Provided during the period | 92 | 183 | 275
As at 31 March 2025 | 92 | 366 | 458

...CONTINUED
Page 2
Page 3
Healthcaps Europe Ltd
Notes to the Financial Statements (continued)
For The Year Ended 31 March 2025

Net Book Value
As at 31 March 2025 | 276 | 367 | 643
As at 1 April 2024 | - | 550 | 550

5. Stocks

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Finished goods | 1,140,222 |  | 739,067

6. Debtors

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Due within one year
Trade debtors | 399,179 |  | 758,824
Prepayments and accrued income | 36,080 |  | 35,805
| 435,259 |  | 794,629

7. Creditors: Amounts Falling Due Within One Year

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Trade creditors | 2,026,698 |  | 1,649,894
VAT | 75,720 |  | 93,080
Accruals and deferred income | 10,009 |  | 5,051
| 2,112,427 |  | 1,748,025

8. Share Capital

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Allotted, Called up and fully paid | 1 |  | 1

Page 3